Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

PCT Europe 2015

Big Pharma; Big bureaucracy; Big trial delays, says PCT panel

26-Nov-2015 - Big Pharma bureaucracy makes trials less efficient but listening to CRO partners can help reverse this, say experts from Pfizer, Bayer and  Grunenthal.


Strategic CRO relationships no more effective than traditional models, Tufts

25-Nov-2015 - Inconsistent practices and a lack of trust are restricting sponsors from fully realising the potential of CRO strategic partnerships, according to Tufts' Director Kenneth Getz.

Megamerger Pfall-out? $160bn Pfizer-Allergan deal to hit CROs in short-term, analysts

24-Nov-2015 - The $160bn Pfizer-Allergan megamerger could lead to booking cancellations in the short-term say analysts, but CROs – especially Icon, Parexel and PPD - should ultimately benefit.

Dispatches from PCT

Patient-centric trials to give CROs competitive edge, say sponsors

19-Nov-2015 - A more patient-focused approach will expedite clinical trials and responsive CROs will have the competitive advantage, say AstraZeneca, EMD and Bayer.

Dispatches from PCT Europe

Apple and Google needed to make sense of growing clinical data mass, say experts

19-Nov-2015 - With data becoming growingly important in clinical trials, CROs and sponsors must embrace companies like Apple and Google to manage it, say panellists at PCT Europe.

Dispatches from PCT Europe

Future epidemic trials must cut through red tape, says Ebola researcher

19-Nov-2015 - A professor who conducted fast-track trials during last year’s Ebola outbreak says next time such trials must be part of humanitarian response… because there will be a next time.

What you missed from PCT Europe 2015

Hamburg begrüßt global clinical trials community

18-Nov-2015 - Partnerships in Clinical trials (PCT) takes place in Hamburg, Germany this week and Outsourcing-Pharma is here to report the latest news and developments in the CRO world.


US plans to require trial consent publication

18-Nov-2015 - The US government may require companies running clinical trials to post their informed consent forms publicly, under rules proposed by the Department of Health and Human Services (HHS).

New regulation will drive EU clinical trials, but are you ready for it?

17-Nov-2015 - The new EU clinical trial regulation will overhaul the sector according to SynteractHCR, but are CROs prepared for the extra resources and tighter deadlines it will produce?

Pierre Fabre deploys biosensors to enrich clinical trial data

17-Nov-2015 - Researchers at Pierre Fabre have started to use implantable chips as biosensors to improve the data gathered whilst monitoring clinical trial subjects.

CRO 'war on talent' could be ended through CRA simulation, says ex-monitor

16-Nov-2015 - A shortage of Clinical Research Associates (CRAs) is fuelling the “war on talent” among CROs according to an ex-monitor, who says a pre-hire simulation service can turn focus from retention...

News in brief

Almac and Illumina partner on next-gen in vitro assays

13-Nov-2015 - Northern Ireland CDMO Almac is working with US gene testing company Illumina to create next-generation sequencing diagnostic assays.

Quintiles: Innovation and integration drives Apple ResearchKit input

13-Nov-2015 - Quintiles will provide its open source code to tech giant Apple’s ResearchKit framework to help create more efficient and integrated clinical trial apps.

WuXi inks CV development and manufacture deal with Eli Lilly in China

12-Nov-2015 - WuXi PharmaTech will develop and manufacture a cardiovascular candidate for Eli Lilly in China through a strategic collaboration.

Parexel expands late-phase service focus through Access division

10-Nov-2015 - Parexel has reorganised its Phase IIIb/IV offerings to cope with growing demand in market access and product lifecycle services from pharma firms.

Accelerated access

UK innovation drive will change licensing, reimbursement and trials

05-Nov-2015 - A UK government report on accelerated access to medicines proposes overhauling conditional licensing and reimbursement pathways to drive drug development.

PRA assessing 'underperforming' JV in light of WuXi going private

04-Nov-2015 - Three year on, a joint venture with WuXi Pharmatech is underperforming according to PRA management and could be renegotiated when WuXi goes private.

Sponsor survey: Covance, Quintiles, PPD to dominate the CRO space

03-Nov-2015 - Covance, Quintiles and PPD are expected to lead the CRO space going forward according to a sponsor survey from the Life Science Strategy Group.

'Highest ever' cancellation rate impairs Parexel's Q1 FY16 results

02-Nov-2015 - Parexel has lowered its revenue guidance for the year following cancellations worth $305m in its first quarter FY2016.

News focus

Placebo response may be making pain trials tougher

02-Nov-2015 - It has been getting harder and harder for trial sponsors to show that drugs intended to treat neuropathic pain are effective - and the reason is surprising.

CROs engaging in a ‘war on talent’, Quintiles CEO says

30-Oct-2015 - The fight between CROs for clinical research associates (CRAs) and people with certain other skillsets is hotting up, with both Icon and Quintiles identifying it as an issue faced by...

Pfizer-Allergan megamerger report prompts speculation about fallout for CROs

29-Oct-2015 - Reports Pfizer is considering buying Allergan to create a company worth $330bn have once again raised fears of disruption for contract research organisations (CRO), although there are reasons to think...

Pressure group floats idea of government-backed clinical trial awareness campaign

29-Oct-2015 - The Coalition for Clinical Trials Awareness (CCTA) has called for a federally-supported public health campaign to make people more aware of drug research and the value of participating in studies. ...

Russia's clinical trial approvals 'on the increase'

26-Oct-2015 - The number of clinical trials given the green light in Russia has increased 13% in the third quarter of the year, which could be thanks in part to a reduction...

Novartis joint venture helps virtual trial CRO to $6.5m fundraising round

26-Oct-2015 - Science 37 has raised $6.5m (€5.7m) from Lux Capital and dRx Capital, the fund set up by Novartis and Qualcomm, to advance its virtual clinical trial service business.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...